Curr Pharm Biotechnol. 2007 Dec;8(6):337-43.

RNAi screening for therapeutic targets in human malignancies.

Source

Department of Biomedicine, University of Bergen, Bergen, Norway.

Abstract

The advent of RNA interference (RNAi) based library screening approaches has sparked a surge in loss-of-function genetic screens. Several recent screens have aimed to identify novel regulators of cancer-related phenotypes. These employ various tumor cell types to model malignant cell functions and use different RNAi effector library approaches to reveal a cache of novel tumor regulators. This review surveys recent RNAi screens conducted in transformed human cells.

PMID:: 18289042; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

RNA, Small Interfering

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Icon for Bentham Science Publishers Ltd.

Save items

Related citations in PubMed

Integrated functional, gene expression and genomic analysis for the identification of cancer targets. [PLoS One. 2009]
Integrated functional, gene expression and genomic analysis for the identification of cancer targets.
Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, Mackay A, Mein CA, Natrajan R, Savage K, Tamber N, et al. PLoS One. 2009; 4(4):e5120. Epub 2009 Apr 9.
Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens. [BMC Bioinformatics. 2008]
Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.
Yin Z, Zhou X, Bakal C, Li F, Sun Y, Perrimon N, Wong ST. BMC Bioinformatics. 2008 Jun 5; 9:264. Epub 2008 Jun 5.
Review [RNA interference (RNAi) and its therapeutic potential in cancer]. [Rev Invest Clin. 2010]
Review [RNA interference (RNAi) and its therapeutic potential in cancer].
Vázquez-Vega S, Contreras-Paredes A, Lizano-Soberón M, Amador-Molina A, García-Carrancá A, Sánchez-Suárez LP, Benítez-Bribiesca L. Rev Invest Clin. 2010 Jan-Feb; 62(1):81-90.
Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. [Cancer Res. 2007]
Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.
Morgan-Lappe SE, Tucker LA, Huang X, Zhang Q, Sarthy AV, Zakula D, Vernetti L, Schurdak M, Wang J, Fesik SW. Cancer Res. 2007 May 1; 67(9):4390-8.
Review How will RNAi facilitate drug development? [Sci STKE. 2005]
Review How will RNAi facilitate drug development?
Bartz S, Jackson AL. Sci STKE. 2005 Aug 2; 2005(295):pe39. Epub 2005 Aug 2.

See reviews... See all...

Cited by 2 PubMed Central articles

Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector. [Radiat Res. 2009]
Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector.
Jiang J, McDonald PR, Dixon TM, Franicola D, Zhang X, Nie S, Epperly LD, Huang Z, Kagan VE, Lazo JS, et al. Radiat Res. 2009 Oct; 172(4):414-22.
Review MicroRNAs: control and loss of control in human physiology and disease. [World J Surg. 2009]
Review MicroRNAs: control and loss of control in human physiology and disease.
Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. World J Surg. 2009 Apr; 33(4):667-84.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

RNAi screening for therapeutic targets in human malignancies.
RNAi screening for therapeutic targets in human malignancies.
Curr Pharm Biotechnol. 2007 Dec ;8(6):337-43.

PubMed
Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity i...
Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients?
CNS Neurol Disord Drug Targets. 2008 Feb ;7(1):20-7.

PubMed
The role of LEF/TCF factors in neoplastic transformation.
The role of LEF/TCF factors in neoplastic transformation.
Curr Mol Med. 2008 Feb ;8(1):38-50.

PubMed
Role of sulfonamide group in matrix metalloproteinase inhibitors.
Role of sulfonamide group in matrix metalloproteinase inhibitors.
Curr Med Chem. 2008 ;15(4):368-73.

PubMed
Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfe...
Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.
Curr Med Chem. 2008 ;15(3):284-304.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: